期刊文献+

格拉司琼预防化疗所致消化道反应的临床疗效分析 被引量:1

下载PDF
导出
摘要 目的探讨格拉司琼预防化疗所致消化道反应的临床效果。方法40例恶性肿瘤患者,化疗当天及第2~5天每日静滴格拉司琼3mg一次。结果用格拉司琼后在化疗第1~5天无恶心和轻度恶心的患者占62.5%~82.5%,对急性呕吐的有效率达92.5%,对迟发性呕吐有效率在82.5%~97.5%之间。结论格拉司琼对减轻化疗药物所致的恶心反应、对控制急性呕吐及迟发性呕吐疗效与恩丹西酮相当,明显优于胃复安,且副作用小,是一种安全有效的止呕药。
出处 《西南军医》 2007年第1期39-40,共2页 Journal of Military Surgeon in Southwest China
  • 相关文献

参考文献3

二级参考文献3

  • 1Perez EA. Comparative efficacy of oral and intravenous granisetron for the prevention of acute chemotherapy-induced emesis[ J ]. Clin Ther,1996,18(4): 578-590.
  • 2Blower PA.Pharmacologic profile or oral granisetron(Kytris Tablets)[J]. Semin Oncol, 1995,22(4) :3-5.
  • 3Marr HE,Davey PT, Bartler AJ.Emerging differences between 5-HT3,receptor antagonists[J]. Anticancer Drugs, 1991,2: 513-518.

共引文献7

同被引文献10

  • 1李玉升,张弘刚,黄镜,迟.依荷芭丽,杨林,宋岩,张雯,胡兴胜,袁芃,王金万.含有CPT-11的联合化疗方案治疗晚期胃肠道癌26例临床观察[J].临床肿瘤学杂志,2004,9(3):265-266. 被引量:15
  • 2Simmonds PC. Palliative chemotherapy for advanced colorectal: systematic review and meta-analysis. Colorectal Cancer Collaborative Group[J]. BMJ,2000,321 (7260) :531-535.
  • 3de Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study [ J]. J Clin Oncol, 1997,15 (2) :808-815.
  • 4Rougier P, Mitry E. Review of the role of CPT-11 in the treatment of colorectal cancer[J]. Clin Colorectal Cancer, 2001, 1 (2) :87 -94.
  • 5Armand JP. CPT-11: clicinal experience in phase Ⅰ studies [ J]. Serain Oncol, 1996,23 (1 Suppl 3) :27 - 33.
  • 6Saltz LD, Cox JV, Blanke C, et al. Irinotecan plus fluorouracll and leucovorin for metastatic colorectal cancer. Irinotecan Study Group [J]. N Engl J Med,2000, 343(13) :905 -914.
  • 7Abad A, Massuti B, Anton A, et al. Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase Ⅱ study [J]. Acta Oncol,2008,47 (2) :286 - 292.
  • 8Ychou M, Viret F, Kramar A, et al. Tritherapy with fluorouracil/leucovorin, irlnotecan and oxaliplatin (FOLFIRINOX) : a phase Ⅱ study in colorectal cancer patients with non-resectable liver metastases [ J ]. Cancer Chemother Pharmacol, 2007: [ Epub ahead of print].
  • 9Okuno S, Harada M, Yano T, et al. Complete regression of xenografted humancarcinomas by camptothecin analogue-carboxymethyi dextran(T-0128) [J]. Cancer Res, 2000, 60( 11 ) :2988 -2995.
  • 10林万隆,陈强.奥沙利铂的药理作用及临床应用[J].中国肿瘤临床,2000,27(11):872-874. 被引量:333

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部